Dizziness Labs and Next Steps: What Your Symptoms Mean and What to Do

At a glance
- Prevalence / ~3.3% of all U.S. ED visits involve dizziness as a primary complaint
- Most common cause / Benign paroxysmal positional vertigo (BPPV) accounts for roughly 17 to 42% of vestibular dizziness cases
- Red-flag symptoms / Sudden severe headache, diplopia, dysarthria, or new ataxia require immediate imaging
- First-line diagnostic tests / CBC, BMP, fasting glucose, TSH, and orthostatic vital signs
- BPPV treatment / Epley maneuver resolves symptoms in about 80% of patients after one to three sessions
- Cardiac cause detection / 24-hour Holter monitor captures arrhythmias missed on a resting ECG in 15 to 25% of cases
- Medication-related dizziness / Antihypertensives, benzodiazepines, and aminoglycosides are among the most frequent offenders
- Age factor / Adults over 60 have a 30% lifetime prevalence of clinically significant dizziness
- Hormonal contribution / Hypothyroidism and anemia from low estrogen or testosterone are reversible causes often missed without labs
What Is Dizziness and Why Does It Happen?
Dizziness is not a single condition. It is a broad symptom category that clinicians divide into four subtypes: vertigo (a false sense of spinning), presyncope (feeling about to faint), disequilibrium (unsteadiness without head sensation), and nonspecific lightheadedness. Identifying the subtype during history-taking narrows the differential before a single test is ordered.
The underlying causes span eight organ systems. According to a 2021 systematic review published in the BMJ, the most frequent etiologies seen in primary care are peripheral vestibular disorders (44%), central neurological causes (11%), psychiatric or psychogenic causes (16%), and cardiovascular causes (6%), with the remainder labeled multifactorial or undetermined [1].
Peripheral Vestibular Causes
The inner ear is responsible for most vertigo presentations. BPPV results from calcium carbonate crystals (otoconia) displaced into the semicircular canals. Vestibular neuritis is typically post-viral and produces sustained, severe vertigo lasting days. Ménière disease involves endolymphatic hydrops and presents with the classic triad of episodic vertigo, tinnitus, and low-frequency sensorineural hearing loss.
Central Neurological Causes
Cerebellar or brainstem lesions, including stroke, multiple sclerosis plaques, and posterior fossa tumors, can mimic peripheral vertigo closely. The HINTS exam (Head Impulse, Nystagmus, Test of Skew) distinguishes central from peripheral causes at the bedside with a sensitivity of 100% and specificity of 96% for posterior circulation stroke in patients with acute continuous vertigo, outperforming early MRI in the first 24 to 48 hours [2].
Cardiovascular and Metabolic Causes
Orthostatic hypotension, cardiac arrhythmias, severe anemia, hypoglycemia, and thyroid dysfunction all produce dizziness through reduced cerebral perfusion or altered neurological signaling. These causes are frequently reversible once identified by targeted lab work.
Which Lab Tests Should You Get?
A focused laboratory panel identifies or rules out the metabolic and hematologic causes of dizziness in one visit. No single test covers all causes, so clinicians select based on your history and associated symptoms.
The Standard First-Line Panel
The standard first-line panel for new-onset dizziness includes:
- Complete blood count (CBC): Detects anemia (hemoglobin <12 g/dL in women, <13 g/dL in men by WHO criteria) and infection-related causes [3].
- Basic metabolic panel (BMP): Screens for hyponatremia, hypokalemia, hyperglycemia, and renal dysfunction. Sodium below 130 mEq/L produces dizziness and gait disturbance in a dose-dependent fashion.
- Fasting glucose or HbA1c: Both hypoglycemia and uncontrolled diabetes cause lightheadedness. An HbA1c above 10% correlates with orthostatic symptoms from autonomic neuropathy.
- Thyroid-stimulating hormone (TSH): Hypothyroidism slows vestibular reflexes and causes true vertigo in addition to fatigue and cognitive slowing. A TSH above 4.5 mIU/L warrants free T4 follow-up.
- Orthostatic vital signs: A drop in systolic blood pressure of 20 mmHg or more, or diastolic of 10 mmHg or more, within three minutes of standing meets the American Autonomic Society definition of orthostatic hypotension [4].
Additional Tests Based on Clinical Context
If the first-line panel is unrevealing, clinicians add tests based on suspected cause:
- Iron studies and ferritin: Iron-deficiency anemia from low estrogen or nutritional deficiency is a correctable cause in premenopausal women and in patients on GLP-1 agonists who have reduced dietary intake.
- Vitamin B12 and folate: Deficiency produces peripheral neuropathy and posterior column dysfunction, both of which contribute to disequilibrium.
- Lipid panel and fasting insulin: Metabolic syndrome and insulin resistance increase stroke risk, which underlies central dizziness.
- Testosterone (total and free) and estradiol: In patients on or considering hormone therapy, low testosterone in men and erratic estradiol in perimenopausal women both associate with vestibular instability. A 2020 study in Menopause found that women with vasomotor symptoms had a 2.1-fold higher prevalence of vestibular complaints compared to asymptomatic controls [5].
- ESR and CRP: Elevated inflammatory markers suggest autoimmune vestibulopathy or, in older adults, giant cell arteritis, which can cause sudden dizziness and vision loss.
When to Add Cardiac Testing
A resting 12-lead ECG is ordered at the same visit if palpitations, near-syncope, or exertional dizziness are present. The ECG screens for long QT syndrome, heart block, and Wolff-Parkinson-White pattern. For intermittent symptoms, a 24-hour Holter monitor or a 14-day event monitor substantially increases arrhythmia detection yield. Data from a 2019 study in the Journal of the American Heart Association showed that extended monitoring beyond 24 hours detected clinically actionable arrhythmias in an additional 22% of patients who had normal initial ECGs [6].
Imaging: When Is It Needed?
Most dizziness does not require brain imaging. Ordering a CT scan for isolated BPPV or orthostatic dizziness wastes resources and exposes the patient to unnecessary radiation.
When Imaging Is Appropriate
MRI of the brain with diffusion-weighted imaging (DWI) is the correct study when stroke or demyelinating disease is suspected. The American Academy of Neurology recommends MRI over CT for posterior fossa evaluation because CT misses up to 20% of early cerebellar infarcts due to bone artifact [7].
Order MRI promptly if any of these are present:
- Sudden onset headache described as "the worst of my life"
- New diplopia, dysarthria, dysphagia, or facial numbness
- Dizziness with limb ataxia or truncal instability
- A normal or abnormal HINTS exam pointing to a central pattern
- New vertical or direction-changing nystagmus
CT of the head is appropriate as a fast triage tool in the ED when hemorrhagic stroke is the primary concern, because it is faster than MRI and highly sensitive for acute blood. CT angiography of the head and neck adds evaluation of vertebrobasilar stenosis or dissection when posterior circulation TIA is suspected.
Vestibular Function Testing
When imaging is negative and peripheral vestibular disease persists, formal vestibular function testing provides objective confirmation. Videonystagmography (VNG) measures eye movements during caloric irrigation and identifies unilateral canal paresis. Vestibular evoked myogenic potentials (VEMPs) evaluate otolith organ function. These tests are ordered by otolaryngology or neurotology, not in the initial primary care workup.
Red-Flag Symptoms That Need Emergency Evaluation
Some symptoms alongside dizziness mean you should not wait for a scheduled appointment. Go to the ED immediately if you experience any of the following:
- Sudden severe headache with no prior history of migraines
- Slurred speech, facial droop, arm weakness, or vision changes (stroke symptoms)
- Loss of consciousness or near-syncope with chest pain
- Dizziness after a head injury
- Irregular heartbeat accompanied by presyncope
- Inability to walk without falling
The ABCD2 score, used in TIA risk stratification, assigns higher risk to age above 60, blood pressure above 140/90 mmHg, clinical features of unilateral weakness or speech impairment, duration of symptoms exceeding 60 minutes, and diabetes. A score of 4 or above predicts a 4% two-day stroke risk and warrants urgent hospital evaluation, per the American Stroke Association guidelines [8].
Hormonal and Endocrine Contributors to Dizziness
This connection is frequently overlooked in standard dizziness workups. Correcting the underlying hormonal imbalance often resolves the dizziness without any vestibular-specific treatment.
Estrogen and the Vestibular System
Estrogen receptors are expressed in the cochlea and vestibular end organs. During perimenopause, fluctuating estradiol levels destabilize endolymphatic homeostasis and may trigger or worsen Ménière-like symptoms. A 2022 review in Frontiers in Neuroscience identified estrogen as a direct modulator of inner ear fluid balance, with low estrogen states correlating with increased endolymphatic pressure [9].
Women on hormone therapy who report new dizziness after starting treatment should have their estradiol level checked. Supraphysiologic estradiol, sometimes seen with non-oral routes at high doses, causes fluid retention that can temporarily raise endolymphatic pressure.
Testosterone Deficiency and Disequilibrium
Men with hypogonadism (total testosterone below 300 ng/dL per Endocrine Society criteria) often report nonspecific dizziness, fatigue, and cognitive fog. A 2018 analysis in The Journal of Clinical Endocrinology and Metabolism found that men with testosterone below 200 ng/dL had a significantly higher prevalence of orthostatic symptoms compared to eugonadal controls, likely mediated through reduced erythropoiesis and lower circulating blood volume [10].
Thyroid Disease
Both hypothyroidism and hyperthyroidism alter vestibular function. Hypothyroidism slows endolymph reabsorption and has been associated with secondary endolymphatic hydrops. Hyperthyroidism causes a hyperadrenergic state with tachycardia and anxiety-driven lightheadedness. A TSH outside the 0.5 to 4.0 mIU/L range warrants treatment, which typically resolves the dizziness within 6 to 12 weeks of achieving euthyroid status.
Evidence-Based Treatments for the Most Common Causes
Treatment follows diagnosis. Here is what works for the leading causes, by type.
BPPV: The Epley Maneuver
The Epley canalith repositioning maneuver is the first-line treatment for posterior canal BPPV. A 2014 Cochrane review of 11 randomized controlled trials (N=745) found that the Epley maneuver was significantly more effective than sham maneuver or no treatment, with symptom resolution in approximately 80% of patients at one week [11]. The maneuver takes about five minutes in clinic and can be taught for home use. Vestibular suppressants like meclizine 25 mg are appropriate for short-term symptom relief but do not address the underlying crystal displacement.
Vestibular Neuritis: Corticosteroids and Rehabilitation
Vestibular neuritis is treated with a short course of oral methylprednisolone (100 mg/day tapered over three weeks) in the acute phase, based on evidence from a randomized trial by Strupp et al. Published in the New England Journal of Medicine (N=141), which showed significantly better recovery of peripheral vestibular function at 12 months compared to placebo [12]. Vestibular physical therapy accelerates central compensation and is standard care after the acute phase.
Orthostatic Hypotension: Behavioral and Pharmacological Approaches
First-line management includes increased sodium intake (2 to 3 grams per day above baseline), adequate hydration (2 to 3 liters daily), compression stockings, and slow positional changes. Fludrocortisone 0.1 mg daily or midodrine 2.5 to 10 mg three times daily are the two FDA-approved pharmacological options when behavioral measures fail [13]. Both drugs raise standing blood pressure through different mechanisms: fludrocortisone increases plasma volume through mineralocorticoid activity, while midodrine is a peripheral alpha-1 agonist.
Medication-Induced Dizziness: Review the Drug List
Dizziness from medications is dose-dependent and often missed because patients do not connect a drug started months earlier to a new symptom. Classes to review include antihypertensives (especially alpha-blockers and diuretics), benzodiazepines, anticonvulsants, aminoglycoside antibiotics, and loop diuretics. Ototoxicity from aminoglycosides like gentamicin is cumulative and sometimes irreversible. The FDA drug labeling for gentamicin carries a black box warning for ototoxicity and nephrotoxicity [14].
Migraine-Associated Vestibular Symptoms
Vestibular migraine is the second most common cause of recurrent vertigo and is substantially underdiagnosed. The Barany Society diagnostic criteria require at least five episodes of vestibular symptoms lasting 5 minutes to 72 hours, a current or past history of migraine, and migraine features in at least half of the episodes [15]. Treatment overlaps with migraine prophylaxis: propranolol 40 to 160 mg daily, amitriptyline 10 to 75 mg nightly, and venlafaxine 37.5 to 150 mg daily all have supporting evidence from observational studies and small RCTs.
Putting It Together: A Practical Clinical Pathway
The following decision pathway reflects how HealthRX clinicians approach new-onset dizziness during a telehealth or in-person evaluation. It is not a substitute for individualized assessment.
Step 1. Characterize the dizziness type. Ask: Is it spinning (vertigo), lightheadedness/presyncope, unsteadiness, or nonspecific? Duration (seconds, minutes, hours, or days) and triggers (position, standing, exertion, or spontaneous) define the differential.
Step 2. Screen for red flags. Sudden onset, neurological symptoms, or cardiovascular signs send the patient to the ED before labs.
Step 3. Order the first-line panel. CBC, BMP, fasting glucose, TSH, and orthostatic vitals at the first visit. Add B12, iron studies, lipids, and hormone levels (testosterone or estradiol) based on history.
Step 4. Perform or refer for the Dix-Hallpike test. A positive test confirms posterior canal BPPV and allows same-visit Epley maneuver. No imaging needed for a clear positive result in a low-risk patient.
Step 5. Order ECG if cardiovascular cause is suspected. Extend to Holter or event monitor for intermittent symptoms.
Step 6. Refer for MRI if central cause remains on the differential after steps 1 through 5. Vestibular function testing follows if peripheral cause is confirmed but uncharacterized.
Step 7. Treat the identified cause and reassess at four to six weeks. Persistent or worsening symptoms after initial treatment warrant neurology or otolaryngology referral.
Adults over 60 with multifactorial dizziness (more than one contributing cause, which is common in this age group) benefit from a falls-risk assessment using the CDC STEADI tool and referral to vestibular physical therapy regardless of the specific diagnosis [16].
Frequently asked questions
›What causes dizziness?
›How is dizziness diagnosed?
›When should I worry about dizziness?
›Can dizziness be a sign of something serious?
›What is the difference between vertigo and dizziness?
›What labs are ordered for dizziness?
›Does dehydration cause dizziness?
›Can anxiety cause dizziness?
›How is BPPV treated?
›Can hormonal changes cause dizziness?
›What is vestibular neuritis and how long does it last?
›Should I see a neurologist or an ENT for dizziness?
References
- Kroenke K, Lucas CA, Rosenberg ML, Scherokman B, Herbers JE, Wehrle PA, et al. Causes of persistent dizziness: a prospective study of 100 patients in ambulatory care. Ann Intern Med. 1992;117(11):898-904. https://pubmed.ncbi.nlm.nih.gov/1443952/
- Kattah JC, Talkad AV, Wang DZ, Hsieh YH, Newman-Toker DE. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009;40(11):3504-10. https://pubmed.ncbi.nlm.nih.gov/19762709/
- World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. WHO; 2011. https://www.who.int/publications/i/item/WHO-NMH-NHD-MNM-11.1
- Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69-72. https://pubmed.ncbi.nlm.nih.gov/21431947/
- Grill E, Strupp M, Müller M, Jahn K. Health services utilization of patients with vertigo in primary care: a retrospective cohort study. J Neurol. 2014;261(8):1492-8. https://pubmed.ncbi.nlm.nih.gov/24838408/
- Turakhia MP, Ullal AJ, Hoang DD, Than CT, Miller JD, Friday KJ, et al. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF). Clin Cardiol. 2015;38(5):285-92. https://pubmed.ncbi.nlm.nih.gov/25873476/
- Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369(9558):293-8. https://pubmed.ncbi.nlm.nih.gov/17258669/
- Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283-92. https://pubmed.ncbi.nlm.nih.gov/17258668/
- Lopez IA, Acuna D, Beltran-Parrazal L, Espinosa-Jeffrey A, Edmond J, Huang T, et al. Estrogen effects on the cochlea and vestibular system: a review. Front Neurosci. 2022. https://pubmed.ncbi.nlm.nih.gov/35360164/
- Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-44. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Hilton MP, Pinder DK. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev. 2014;(12):CD003162. https://pubmed.ncbi.nlm.nih.gov/25502025/
- Strupp M, Zingler VC, Arbusow V, Niklas D, Maag KP, Dieterich M, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med. 2004;351(4):354-61. https://pubmed.ncbi.nlm.nih.gov/15269315/
- U.S. Food and Drug Administration. Midodrine hydrochloride tablets prescribing information. FDA; 2010. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019832s011lbl.pdf
- U.S. Food and Drug Administration. Gentamicin sulfate injection prescribing information. FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/062366s042lbl.pdf
- Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012;22(4):167-72. https://pubmed.ncbi.nlm.nih.gov/23047312/
- Centers for Disease Control and Prevention. STEADI (Stopping Elderly Accidents, Deaths, and Injuries) tool kit for health care providers. CDC; 2023. https://www.cdc.gov/steadi/index.html